Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Valacyclovir × 1 year × Clear all

Phase

Phase 2 5 Phase 1 2 Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 217 Carboplatin 213 Cisplatin 199 Paclitaxel 173 Gemcitabine 147 Docetaxel 125 Capecitabine 107 Cyclophosphamide 104 Pemetrexed 99 Dexamethasone 99 Specimen Handling 98 Magnetic Resonance Spectroscopy 96 Radiotherapy 92 Oxaliplatin 92 Doxorubicin 91 Fluorouracil 82 Bevacizumab 80 Nivolumab 75 Rituximab 72 Leucovorin 71 Vincristine 69 durvalumab 65 Lenalidomide 65 atezolizumab 60 Radiation 60 Irinotecan 59 Etoposide 59 Prednisone 58 130-nm albumin-bound paclitaxel 57 Letrozole 55

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01436968 2025-07-30

PrTK03

Candel Therapeutics, Inc.

Phase 3 Active not recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡